A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. (Q48636986)
Jump to navigation
Jump to search
scientific article published in July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. |
scientific article published in July 2011 |
Statements
1 reference
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. (English)
1 reference
John Hainsworth
1 reference
Adam Brufsky
1 reference
Karen Hoelzer
1 reference
Thaddeus Beck
1 reference
Robert Whorf
1 reference
Mark Keaton
1 reference
Padma Nadella
1 reference
Elisa Krill-Jackson
1 reference
Joan Kroener
1 reference
Edward Middleman
1 reference
Michael Frontiera
1 reference
Devchand Paul
1 reference
Timothy Panella
1 reference
Jane Bromund
1 reference
Luping Zhao
1 reference
Mauro Orlando
1 reference
Fritz Tai
1 reference
Martin D Marciniak
1 reference
Coleman Obasaju
1 reference
1 July 2011
1 reference
11
1 reference
4
1 reference
211-220
1 reference